ID

13206

Descrição

Chemotherapy Plus Vaccination to Treat Mantle Cell Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT00005780

Link

https://clinicaltrials.gov/show/NCT00005780

Palavras-chave

  1. 24/01/2016 24/01/2016 -
Transferido a

24 de janeiro de 2016

DOI

Para um pedido faça login.

Licença

Creative Commons BY 4.0

Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Comentários do grupo de itens para :

Comentários do item para :

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

Eligibility Mantle Cell Lymphoma NCT00005780

Eligibility Mantle Cell Lymphoma NCT00005780

Criteria
Descrição

Criteria

tissue diagnosis of mantle cell lymphoma (confirmed in laboratory of pathology). blastic cell variant will be eligible.
Descrição

mantle cell lymphoma

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0030664
UMLS CUI [1,2]
C0334634
age greater than or equal to 18.
Descrição

age

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0001779
previously untreated with cytotoxic chemotherapy. patients may have received local radiation or a short course of steroids for control of symptoms.
Descrição

chemotherapy

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0392920
all stages of disease.
Descrição

disease stage

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0699749
lymph node of greater than or equal to 2 cm accessible for biopsy/harvest or greater than 1000/microliters of circulating tumor cells in the blood.
Descrição

lymph nodes, circulating tumor cells

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0024204
UMLS CUI [2]
C3272887
ecog performance status of less than or equal to 3.
Descrição

ecog

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1520224
adequate major organ function (serum creatinine 1.5 mg/dl or creatinine clearance greater than 60 ml/min; bilirubin less than 2 mg/dl (total) except less than 5 mg/dl in patients with gilbert's syndrome as defined by greater than 80% unconjugated; anc greater than 1000 and platelets greater than 100,000) unless impairment due to organ involvement by lymphoma.
Descrição

organ function

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0201976
UMLS CUI [2]
C0373595
UMLS CUI [3]
C1278039
UMLS CUI [4]
C0948762
UMLS CUI [5]
C0032181
no active symptomatic ischemic heart disease, myocardial infarction or congestive heart failure within the past year. if muga is obtained, the lvef should exceed 40%.
Descrição

cardiac disease

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0018799
ability to give informed consent.
Descrição

informed consent

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Descrição

Exclusion Criteria

Alias
UMLS CUI
C0680251
antibodies to hiv or presence of hepatitis b surface antigen.
Descrição

hiv, hepatitis b

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0019683
UMLS CUI [2]
C0019168
pregnant or lactating.
Descrição

pregnant or lactating

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
prior malignancy in past 5 years except squamous or basal cell carcinoma or curatively treated in situ of the cervix.
Descrição

malignancy

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0006826
involvement of central nervous system by lymphoma.
Descrição

cns involvement

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0449389

Similar models

Eligibility Mantle Cell Lymphoma NCT00005780

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
mantle cell lymphoma
Item
tissue diagnosis of mantle cell lymphoma (confirmed in laboratory of pathology). blastic cell variant will be eligible.
boolean
C0030664 (UMLS CUI [1,1])
C0334634 (UMLS CUI [1,2])
age
Item
age greater than or equal to 18.
boolean
C0001779 (UMLS CUI [1])
chemotherapy
Item
previously untreated with cytotoxic chemotherapy. patients may have received local radiation or a short course of steroids for control of symptoms.
boolean
C0392920 (UMLS CUI [1])
disease stage
Item
all stages of disease.
boolean
C0699749 (UMLS CUI [1])
lymph nodes, circulating tumor cells
Item
lymph node of greater than or equal to 2 cm accessible for biopsy/harvest or greater than 1000/microliters of circulating tumor cells in the blood.
boolean
C0024204 (UMLS CUI [1])
C3272887 (UMLS CUI [2])
ecog
Item
ecog performance status of less than or equal to 3.
boolean
C1520224 (UMLS CUI [1])
organ function
Item
adequate major organ function (serum creatinine 1.5 mg/dl or creatinine clearance greater than 60 ml/min; bilirubin less than 2 mg/dl (total) except less than 5 mg/dl in patients with gilbert's syndrome as defined by greater than 80% unconjugated; anc greater than 1000 and platelets greater than 100,000) unless impairment due to organ involvement by lymphoma.
boolean
C0201976 (UMLS CUI [1])
C0373595 (UMLS CUI [2])
C1278039 (UMLS CUI [3])
C0948762 (UMLS CUI [4])
C0032181 (UMLS CUI [5])
cardiac disease
Item
no active symptomatic ischemic heart disease, myocardial infarction or congestive heart failure within the past year. if muga is obtained, the lvef should exceed 40%.
boolean
C0018799 (UMLS CUI [1])
informed consent
Item
ability to give informed consent.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
hiv, hepatitis b
Item
antibodies to hiv or presence of hepatitis b surface antigen.
boolean
C0019683 (UMLS CUI [1])
C0019168 (UMLS CUI [2])
pregnant or lactating
Item
pregnant or lactating.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
malignancy
Item
prior malignancy in past 5 years except squamous or basal cell carcinoma or curatively treated in situ of the cervix.
boolean
C0006826 (UMLS CUI [1])
cns involvement
Item
involvement of central nervous system by lymphoma.
boolean
C0449389 (UMLS CUI [1])

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial